Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Navneet Virk Hundal

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|September 7, 2015
Longitudinal Perspective on Managing Refractory Eosinophilic EsophagitisJohn Leung, Raman Mehrzad, Navneet Virk Hundal, et al.
The American Journal of Gastroenterology|July 10, 2026
Dupilumab Improves Endoscopic Features in Children Aged 1-11 Years With Eosinophilic Esophagitis: EoE KIDS Study ResultsShauna Schroeder, Mirna Chehade, Calies Menard-Katcher, et al.
Science Immunology|August 14, 2021
Clonally expanded, GPR15-expressing pathogenic effector T<sub>H</sub>2 cells are associated with eosinophilic esophagitisDuncan M Morgan, Bert Ruiter, Neal P Smith, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Journal of Allergy and Clinical Immunology. in Practice|September 7, 2015
Longitudinal Perspective on Managing Refractory Eosinophilic EsophagitisJohn Leung, Raman Mehrzad, Navneet Virk Hundal, et al.
The American Journal of Gastroenterology|July 10, 2026
Dupilumab Improves Endoscopic Features in Children Aged 1-11 Years With Eosinophilic Esophagitis: EoE KIDS Study ResultsShauna Schroeder, Mirna Chehade, Calies Menard-Katcher, et al.
Science Immunology|August 14, 2021
Clonally expanded, GPR15-expressing pathogenic effector T<sub>H</sub>2 cells are associated with eosinophilic esophagitisDuncan M Morgan, Bert Ruiter, Neal P Smith, et al.
Pageof 1